Computer Vision SyndromeNCT06913816
Effects Of Optimized Blinking Training on Visual Function and Tear Film Parameters in Individuals With CVS
A study testing Grouyp 1 (without blinking exercises). and EXP group (Routine CVS treatment) in people with Computer Vision Syndrome, run by Superior University at 1 site in Pakistan.
Trial summary
"Computer vision syndrome (CVS), refers to a range of eye and vision issues caused by extended use of computers, tablets, e-readers, and smartphones. Computer users experience visual symptoms, such as eyestrain, headaches, eye discomfort, dry eyes, double vision, and blurred vision, especially after long periods of… Read more about this study
- Who is it for?
- Ages 18 to 40 years
- Conditions the study is for
- Computer Vision Syndrome
- What is being tested?
- Grouyp 1 (without blinking exercises). and EXP group (Routine CVS treatment)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 52 participants
- Where
- 1 sitePakistan
- Study dates
- 20 Mar 2025to 20 Feb 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Individuals aged 18-40 years who work on computers or digital devices for at least 3 to 6 hours daily.
- Both Male and Female.
- Individuals who could undergo a complete ocular examination.
- Presence of symptoms consistent with digital eye strain.
- Presented with eye complaints such as eye fatigue, burning, irritation, redness, and blurred vision due to long-term computer or digital screen use.
- Symptoms worsened during exposure to digital screen light.
Who cannot join
- Use of medications that might influence tear production or ocular surface status (e.g., antihistamines, antidepressants).
- Diagnosed neurological or systemic conditions that impact vision or blink patterns (e.g., Parkinson's disease, multiple sclerosis).
- Individual's with a history of ocular surface diseases such as conjunctivitis or keratitis.
- History of any psychiatric diagnosis."
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects Of Optimized Blinking Training on Visual Function and Tear Film Parameters in Individuals With Computer Vision Syndrome
"Computer vision syndrome (CVS), refers to a range of eye and vision issues caused by extended use of computers, tablets, e-readers, and smartphones. Computer users experience visual symptoms, such as eyestrain, headaches, eye discomfort, dry eyes, double vision, and blurred vision, especially after long periods of looking at screens, whether up close or at a distance.
Read the detailed description
Individuals will be randomly assigned to either an experimental group (group A) receiving OBT with routine rehabilitation CVS management 20-20-20 rule, blue light-blocking glasses, and polyvinyl alcohol eye drops or a control group (group B) receiving only routine rehabilitation, including the 20-20-20 rule, blue light-blocking glasses, and polyvinyl alcohol eye drops. OBT consisted of structured blinking exercises performed thrice daily for three months. Objective outcomes, including tear film parameters and visual function using subjective Computer Vision Syndrome Questionnaire (CVS-Q) shall be evaluated. The collected data will be analysed by using SPSS."
- Conditions
- Computer Vision Syndrome
- Being tested
- Grouyp 1 (without blinking exercises)., EXP group (Routine CVS treatment)
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Grouyp 1 (without blinking exercises).Diagnostic test
Group B (Control Group) The control group will continue receiving only the routine rehabilitation (without blinking exercises). Routine rehabilitation included the 20-20-20 rule, blue light-blocking glasses, and polyvinyl alcohol eye drops.
EXP group (Routine CVS treatment)Combination product
"Group A (Experimental Group): Individuals in the Experimental group will receive Routine CVS treatment with optimized blinking exercise.
Routine rehabilitation includes the 20-20-20 rule, blue light-blocking glasses, and polyvinyl eye drops.
The blinking exercise involved the individuals looking at an object 6 meters away for 5 seconds, followed by complete eyelid closure for 5 seconds. This cycle was repeated for 5 minutes, twice a day."
| Study group | Role | What they receive |
|---|---|---|
| Grouyp 1 (without blinking exercises). | Active comparator | Not described Receives: Diagnostic Test: Grouyp 1 (without blinking exercises). |
| EXP group (Routine CVS treatment) | Experimental | Not described Receives: Combination Product: EXP group (Routine CVS treatment) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Computer Vision Syndrome (CVS-Q)
The Computer Vision Syndrome Questionnaire (CVS-Q) assesses the frequency and intensity of 16 ocular and visual symptoms related to prolonged screen use, with a total score of 6 or more indicating CVS If the total score is ≥6 points, the individual is considered to suffer Computer Vision Syndrome
Measured: 12 Months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Apr 2025
- Study start20 Mar 2025
- Primary completion20 Jun 2025 (estimated)
- Study completion20 Feb 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Computer Vision SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 52 participants (actual)
Sponsor and investigators
- Lead sponsor
- Superior University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Muhammad Naveed Babur, Superior University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06913816
- Sponsor's protocol ID
- MSRSW/Batch-Fall23/810
- Status last verified
- Mar 2025
- First submitted
- 29 Mar 2025
- Last updated
- 6 Apr 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects Of Optimized Blinking Training on Visual Function and Tear Film Parameters in Individuals With Computer Vision Syndrome
- ClinicalTrials.gov ID
- NCT06913816
- Acronym / sponsor ID
- MSRSW/Batch-Fall23/810
- Conditions
- Computer Vision Syndrome
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 52 participants (actual)
- Lead sponsor
- Superior UniversityUniversity, hospital or other
- Study start
- 20 Mar 2025 (actual)
- Primary completion
- 20 Jun 2025 (estimated)
- Study completion
- 20 Feb 2026 (estimated)
- First posted
- 6 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
"Computer vision syndrome (CVS), refers to a range of eye and vision issues caused by extended use of computers, tablets, e-readers, and smartphones. Computer users experience visual symptoms, such as eyestrain, headaches, eye discomfort, dry eyes, double vision, and blurred vision, especially after long periods of looking at screens, whether up close or at a distance.
Detailed description
Individuals will be randomly assigned to either an experimental group (group A) receiving OBT with routine rehabilitation CVS management 20-20-20 rule, blue light-blocking glasses, and polyvinyl alcohol eye drops or a control group (group B) receiving only routine rehabilitation, including the 20-20-20 rule, blue light-blocking glasses, and polyvinyl alcohol eye drops. OBT consisted of structured blinking exercises performed thrice daily for three months. Objective outcomes, including tear film parameters and visual function using subjective Computer Vision Syndrome Questionnaire (CVS-Q) shall be evaluated. The collected data will be analysed by using SPSS."
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Grouyp 1 (without blinking exercises). | Active comparator | Diagnostic Test: Grouyp 1 (without blinking exercises). |
| EXP group (Routine CVS treatment) | Experimental | Combination Product: EXP group (Routine CVS treatment) |
Who may qualify
- Ages
- 18 to 40 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- Individuals aged 18-40 years who work on computers or digital devices for at least 3 to 6 hours daily.
- Both Male and Female.
- Individuals who could undergo a complete ocular examination.
- Presence of symptoms consistent with digital eye strain.
- Presented with eye complaints such as eye fatigue, burning, irritation, redness, and blurred vision due to long-term computer or digital screen use.
Key exclusion criteria (4 listed)
- Use of medications that might influence tear production or ocular surface status (e.g., antihistamines, antidepressants).
- Diagnosed neurological or systemic conditions that impact vision or blink patterns (e.g., Parkinson's disease, multiple sclerosis).
- Individual's with a history of ocular surface diseases such as conjunctivitis or keratitis.
- History of any psychiatric diagnosis."
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Grouyp 1 (without blinking exercises).Group B (Control Group) The control group will continue receiving only the routine rehabilitation (without blinking exercises). Routine rehabilitation included the 20-20-20 rule, blue light-blocking glasses, and polyvinyl alcohol eye drops. | Diagnostic test | Grouyp 1 (without blinking exercises). |
| EXP group (Routine CVS treatment)"Group A (Experimental Group): Individuals in the Experimental group will receive Routine CVS treatment with optimized blinking exercise. Routine rehabilitation includes the 20-20-20 rule, blue light-blocking glasses, and polyvinyl eye drops. The blinking exercise involved the individuals looking at an object 6 meters away for 5 seconds, followed by complete eyelid closure for 5 seconds. This cycle was repeated for 5 minutes, twice a day." | Combination product | EXP group (Routine CVS treatment) |
Primary outcome
Computer Vision Syndrome (CVS-Q)
Time frame: 12 Months
The Computer Vision Syndrome Questionnaire (CVS-Q) assesses the frequency and intensity of 16 ocular and visual symptoms related to prolonged screen use, with a total score of 6 or more indicating CVS If the total score is ≥6 points, the individual is considered to suffer Computer Vision Syndrome
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Apr 2025.
- Individual participant dataSharing planned: No
Related trials for Computer Vision Syndrome
Not yet recruiting
Comparative Effects of Exercises on Pain, Cervical Proprioception, Neck Disability and Visual Performance in Patients With Computer Vision Syndrome.
Computer Vision Syndrome
Not yet recruiting
A Study of Full-Spectrum Screen Lighting for Reducing Screen-Related Eye Fatigue and Dry Eye
Visual Fatigue, Dry Eye
RecruitingObservational study
Longevity Metrics AI/ML Development Study
Aging, Mortality
Not yet recruitingObservational study
A Computer-Assisted Tool for Objective Assessment of Extrapyramidal Symptoms
Extrapyramidal Symptoms, Drug-induced Parkinsonism
Not yet recruiting
AI and Computer Vision-Assisted Telerehabilitation in Fibromyalgia: The FibroIA 2.0 Trial
Fibromyalgia, Fibromyalgia (FM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Grouyp 1 (without blinking exercises). and EXP group (Routine CVS treatment) in people with Computer Vision Syndrome, run by Superior University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 6 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Computer Vision Syndrome (CVS-Q) (time frame: 12 Months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2025.